II International Symposium on Innovations in the Treatment of Coronary Artery Disease and Structural Heart Disease

The II International Symposium on Innovations in the Treatment of Coronary Artery Disease and Structural Heart Disease will take place on July 31st, 2019 at the Syrian-Lebanese Hospital in São Paulo.

Se acerca el IV Simposio de Cardiopatía Isquémica del ICBA

This event seeks to provide a better understanding of indications and clinical and interventional strategies for complex heart conditions, such as left main coronary artery obstructions, patients with acute coronary syndromes, patients at high risk for bleeding and an indication for coronary intervention, as well as percutaneous approaches to aortic stenosis (TAVR), mitral regurgitation, left atrial appendage closure, foramen ovale closure, etc.

Topics will be addressed dynamically and interactively, with clinical case presentations, conferences, and discussions, so as to provide information and improve the integration of new technologies into clinical practice.

Furthermore, this event will feature first-class international faculties.

Special Benefits

50% Off in Registration Fees for SOLACI Members!

SOLACI members registering for this event enjoy a 50% discount in the registration fee. Select “SOLACI member” in the registry system for this event and follow the instructions.

Those attending the SOLACI-SBHCI 2019 Congress will have a 50% discount on registrations to the II International Symposium of Innovations in the Treatment of Coronary and Structural Diseases

More information and registration HERE (this website is in portuguese language)

If you have questions or queries, write to secretaria.iep@hsl.org.br

This symposium is destined to: healthcare professionals, cardiologists and interventional cardiologists, cardiovascular surgeons, students, residents, nurses, and multidisciplinary teams seeking to stay updated on the latest transcatheter cardiology strategies.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

SOLACI Wishes You Happy Holidays

From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....